Pharmacy tech company partners with SCPC to bolster its advocacy agenda
Published by McKnight’s LTC News
A Durham, NC-based pharmacy automation technology company is partnering with the association that represents long-term care pharmacists, lending it heft to further its advocacy agenda.
Parata announced last week that it’s becoming a Bronze Level Business Partnership with the Senior Care Pharmacy Coalition, which represents some 350 LTC pharmacies across the U.S. The company says it’s doing so because it wants to reinvest profits toward addressing the concerns of its customers, who first introduced this idea.
“We have an obligation to stay informed about issues in LTC and help any way we can. Our research proved this to be an easy decision to make. It’s a win for all involved,” Mark Longley, Parata’s executive vice president of sales and business development, said in a company announcement.
As part of the Bronze partnership, Parata says it also will take part in the coalition’s annual meeting and Business Partners Summit in July.
Click here to see the original article on the McKnight’s LTC website.
Recent Posts
-
Senior Care Pharmacy Coalition Opposes CMS Final Rule on Minimum Staffing Standards for LTC Facilities
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy sector, released a statement today regarding its opposition to the Centers for Medicare & Medicaid Services (CMS) final rule on minimum staffing standards for long-term care (LTC) facilities.
-
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Drug pricing efforts threaten ‘very existence’ of LTC pharmacies: reps
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
But the president’s plans to expand his administration’s first-ever Medicare drug price negotiations could spell big trouble for the pharmacists who support seniors living in long-term care settings, advocates warned in response.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.